Tech Query: Should you buy Mphasis shares at current levels?
Recently, the stock breached a key resistance at ₹1,800 and recorded a new high
Source: thehindubusinessline.com
Ashish Pathrabe News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ashish Pathrabe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ashish Pathrabe Today - Breaking & Trending Today
Divi's Laboratories faces a key barrier - The Hindu BusinessLine
Divi’s Laboratories faces a key barrier The short-term outlook is negatively biased What is the short-term outlook for Divi’s Laboratories? I would like to buy for a short-term horizon. Ashish Pathrabe Divi’s Laboratories (₹3,846.9): The stock of Divi’s Laboratories has been on a long-term uptrend since bottoming out from the 2017 low of ₹533. Medium as well as the short-term trend are up for the stock. In July 2020, the stock breached a key resistance at ₹2,500 and continued to trend upwards. On Friday, the stock registered a new high at ₹3,867 levels and paused. It face...
Source: thehindubusinessline.com